ThursdayMay 09, 2019 2:39 pm

QualityStocksNewsBreaks – Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) Minimizing Emissions, Providing Decreased Costs

Vaughan, Ontario-based Kontrol Energy (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) offers integrated smart energy technologies that enable organizations to benefit from energy cost savings while minimalizing greenhouse gas (“GHG”) emissions. A recent article discussing the company reads, “The company provides organizational customers with market-based energy solutions designed to lessen their overall cost of energy. This is done while also providing a corresponding decrease in GHG emissions (http://ibn.fm/m9lj0). The benefits to Kontrol’s customers include a high ROI (return on investment) of 30% or more in efficiency measures, with immediate energy savings in the range of 25-30%. Customer benefits also include access to…

Continue Reading

ThursdayMay 09, 2019 11:55 am

QualityStocksNewsBreaks – Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Renews LOI Securing Key Rail Capacity for Shymanivske Project

Canadian iron ore exploration and development company Black Iron (TSX: BKI) (OTC: BKIRF) (GR: BIN) this morning announced its renewal of a Letter of Intent (“LOI”) with Ukraine’s National Railway. Under the agreement, the railway will provide up to 10 Mtpa of capacity to move product from the line located within two kilometers of Black Iron’s Shymanivske Project to Port Yuzhny, a deep water port in the Black Sea. Per the update, unlike many other start-up iron ore mines, the Shymanivske Project has ready accessibility to all essential infrastructure needed for its operation, and Black Iron is renewing vital LOIs…

Continue Reading

ThursdayMay 09, 2019 11:41 am

QualityStocksNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) PharmHouse Enters Significant Supply, Offtake Agreement with Canopy Growth Corp. (TSX: WEED) (NYSE: CGC)

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today announced that its 49 percent-owned portfolio company, PharmHouse Inc., has entered into a second offtake agreement with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) for the purchase of cannabis from its 1.3 million square foot greenhouse facility upon licensing. According to the update, the agreement commits an additional 20 percent of PharmHouse's flowering space, in addition to the 10 percent originally committed in May 2018, to Canopy Growth for the next three years. The agreement provides for the delivery to Canopy Growth a minimum of 25,000 kg and maximum of 45,000 kg of…

Continue Reading

ThursdayMay 09, 2019 10:42 am

QualityStocksNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) to Expand Into Pet CBD Category with Launch of New Hemp-Derived Product Line

Premium functional food and beverage company Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) this morning announced its plans to launch a range of hemp-derived CBD pet products. According to the update, Phivida's new product offerings will be consistent with the company’s strong focus on providing consumers with healthy alternatives to pharmaceuticals, and fully natural and plant-based health and wellness solutions. “Our mission is to provide the highest quality Hemp CBD natural wellness products for our consumers,” Phivida president and CEO Jim Bailey stated in the news release. “By expanding into the pet CBD category, our goal is to provide pet owners…

Continue Reading

ThursdayMay 09, 2019 10:26 am

QualityStocksNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Enters Agreement with Persuasion Brewing Co. to Produce CBD-Infused Beverages

TransCanna Holdings (CSE: TCAN) (FSE: TH8) today announced its entry into a non-binding letter of intent (“LOI”) with Persuasion Brewing Co., a Modesto, California-based private brewing company. According to the update, the companies have agreed to establish, within TransCanna’s recently purchased 196,000-square-foot vertically integrated facility, a Persuasion Brewing division that will produce a variety of CBD-infused non-alcoholic beers. Under the LOI, TransCanna will have exclusive rights to the private labeled beers created at the facility. “Our 196,000-square-foot vertically integrated, cannabis-focused facility is perfectly designed to have a comprehensive bottling and canning line for multiple types of beverages,” TransCanna CEO Jim…

Continue Reading

ThursdayMay 09, 2019 9:51 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Obtains Supply Agreement with British Columbia Liquor Distribution Branch

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, this morning announced that it has obtained a cannabis supply agreement with the BC Liquor Distribution Branch ("BCLDB"), under the brand BC Cannabis Stores. The agreement with British Columbia's public retailer of non-medical cannabis was negotiated in collaboration with Velvet Management Inc. “With very positive feedback on TGOD products from our British Columbia medical patients, we are excited to offer our premium certified organic products to the recreational market,” TGODF CEO Brian Athaide stated in the news release. “As our two Canadian production facilities come…

Continue Reading

WednesdayMay 08, 2019 11:46 am

QualityStocksNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) to Sell Hemp CBD Products in Select Abercrombie & Fitch Locations

Lifestyle-oriented cannabis company Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured in a Bloomberg article earlier this week concerning the firm’s partnership with Abercrombie & Fitch Co. (NYSE: ANF). As noted in the article, Green Growth will sell its Seventh Sense Botanical Therapy body scrubs, bath bombs, cleansing oils, lotions and lip balms in 10 Abercrombie & Fitch stores in Massachusetts, California, Colorado and Nevada. The Bloomberg piece states that the Seventh Sense Botanical Therapy products are “made with CBD derived from hemp, which was legalized with the U.S. farm bill in December and is said by its…

Continue Reading

WednesdayMay 08, 2019 11:08 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Announces Strategic Investment in Califormulations LLC

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced its strategic investment in the newly-formed Califormulations LLC. Per the update, Califormulations will operate out of Columbus, Georgia, serving global branded companies with concept-to-shelf beverage commercialization support, including formulation development, technical services, in-house pilot scale production and contract manufacturing co-ordination. TGOD is expected to work with Califormulations to expedite the U.S. launch of TGOD-branded organic hemp-based CBD beverages, as permitted by local regulations. “We are incredibly excited to partner with Califormulations to further our development of hemp-based CBD beverage products,” Brian Athaide,…

Continue Reading

WednesdayMay 08, 2019 10:54 am

QualityStocksNewsBreaks – SinglePoint Inc. (SING) Unveils National Distribution Program for Promising CBD Product Companies

Technology and investment company SinglePoint (OTCQB: SING) this morning introduced the new “Strategics” program, a strategic national distribution program that will offer qualified fast-growing CBD product companies a route to attain national retail distribution for their products. The Strategics program is offered in partnership with a national distribution company that has nearly $2 billion in annual sales to mass-market stores as well as various regional and national convenience stores. SinglePoint aims to identify and recruit burgeoning companies that manufacture or distribute CBD retail products that wish to have their products distributed nationally. Strategics program partner companies will have additional benefits…

Continue Reading

WednesdayMay 08, 2019 10:11 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Retains Pharmaceutical Branding Agency to Oversee Lead Drug Candidate Naming Process

Clinical-stage, gene-therapy company Genprex (NASDAQ: GNPX) this morning announced that it has retained the services of leading pharmaceutical branding agency, Addison Whitney, representing the next step toward commercialization of its lead drug candidate. Utilizing its 28-year history, Addison Whitney will oversee the proprietary and non-proprietary drug naming process for the company’s drug candidate for non-small cell lung cancer, presently known as Oncoprex(TM) immunogene therapy. “Retaining Addison Whitney is an important step in bringing our drug candidate to market,” Genprex Chairman and CEO Rodney Varner stated in the news release. “Obtaining regulatory approval of proprietary and non-proprietary drug names is a…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered